Global Cord Blood Corporation Announces Receipt of Preliminary Non-Binding Proposal to Acquire the Company
HONG KONG, June 4, 2019 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced that its board of directors has received a no...
Global Cord Blood Corporation Raised Subscription Fee
HONG KONG, April 1, 2019 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced that the Company is increasing its...
Global Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2019
3Q19 Added 23,663 New Subscribers Revenues Up 3.7% YoY to RMB254.2 Million ($37.0 Million) Operating Income Increased to RMB92.6 Million ($13.5 Million) Conference Call to be Held on February 26, 2019 at 8:00 a.m. ET HONG KONG, Feb. 26, 2019 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO...
Global Cord Blood Corporation to Report Third Quarter and First Nine Months Fiscal 2019 Financial Results
HONG KONG, Feb. 19, 2019 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced that it plans to release its unaudited financ...
Global Cord Blood Corporation to Report Third Quarter and First Nine Months Fiscal 2019 Financial Results
HONG KONG, Feb. 19, 2019 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced that it plans to release its unaudited financ...
Global Cord Blood Corporation Announces Results of 2018 Annual General Meeting
HONG KONG, Dec. 6, 2018 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced the results of its 2018 Annual Gene...
Global Cord Blood Corporation Reports Financial Results for the Second Quarter and First Half of Fiscal 2019
2Q19 Added 22,908 New Subscribers Revenues Up 5.3% YoY to RMB247.1 Million ($36.0 Million ) Operating Income Up 37.3% YoY to RMB104.8 Million ($15.3 Million) Non-GAAP Operating Income Up 8.7% YoY to RMB118.2 Million ($17.2 Million) Conference Call to be Held ...
Global Cord Blood Corporation to Report Second Quarter and First Half Fiscal 2019 Financial Results
Earnings Call Scheduled for 8:00 a.m. ET on November 28, 2018 HONG KONG, Nov. 20, 2018 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage servic...
Global Cord Blood Corporation to Hold Annual General Meeting of Shareholders in Hong Kong on December 5, 2018
HONG KONG, Sept. 21, 2018 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced that the Company will hold its 20...
Global Cord Blood Corporation Reports Financial Results for the First Quarter of Fiscal 2019
1Q19 Added 20,601 New Subscribers Revenues Increased to RMB233.8 Million ($35.3 Million) Operating Income Up 15.0% YoY to RMB95.4 Million ($14.4 Million) Non-GAAP Operating Income Up 17.7% YoY to RMB108.6 Million ($16.4 Million) Conference Call to be Held on August 24, 2018 at 8:00 a.m. ET HONG KO...
Global Cord Blood Corporation Announces the Results of Scrip Dividend Elections
HONG KONG, Aug. 18, 2018 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced the results of the scrip dividend ...
Global Cord Blood Corporation to Report First Quarter Fiscal 2019 Financial Results
HONG KONG, Aug. 16, 2018 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company") today announced that it plans to release financial results for the first quarter fiscal 2019 onThursday, August 23, 2018, after the market close. The Company will host a conference call at 8:00 a.m...
Global Cord Blood Corporation Files Its Annual Report on Form 20-F
HONG KONG, July 24, 2018 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced that the Company filed its Annual ...
June 28, 2018 Open Letter from Jayhawk Capital to Sanpower Group regarding Global Cord Blood Corp
NEW YORK, June 28, 2018 /PRNewswire/ -- The following is an open letter sent June 28, 2018 from Jayhawk Capital, a significant minority shareholder of Global Cord Blood Corp (NYSE: CO), to Sanpower Group regarding Global Cord Blood Corp (NYSE: CO). Congratulations on finally completing the ...
Global Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2018
- Added 21,390 New Subscribers in 4Q18 - 4Q18 Revenues Amounted to RMB233.0 Million ($37.1 Million) - 4Q18 Operating Income Amounted to RMB42.2 Million ($6.7 Million) - 4Q18 Non-GAAP Operating Income Amounted to RMB102.9 Million ($16.4 Million) - Board Declared Dividend of $0.08 per ordinary share -...
Global Cord Blood Corporation to Report Fourth Quarter and Full Year Fiscal 2018 Financial Results
Earnings Call Scheduled for 8:00 a.m. ET on June 27, 2018 HONG KONG, June 19, 2018 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company") today announced that it plans to release financial results for the fourth quarter and full year fiscal 2018 onTuesday, June 26, 2018, after ...
China Cord Blood Corporation Announces Results of Extraordinary General Meeting of Shareholders to Change Company Name to "Global Cord Blood Corporation"
HONG KONG, March 16, 2018 /PRNewswire/ -- China Cord Blood Corporation (NYSE: CO) ("CCBC" or the "Company"), a leading cord blood banking operator inChina, today announced the results of its extraordinary general meeting of shareholders, which was held onMarch 16, 2018, in Hong Kong S.A.R., China...
China Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2018
* 3Q18 Added 24,229 New Subscribers * 3Q18 Revenues Up 22.0% YOY to RMB245.0 Million ($37.7 Million ) * 3Q18 Operating Income Reached RMB78.4 Million ($12.0 Million) * Conference Call to be Held on February 27, 2018 at 8:00 a.m. ET HONG KONG, Feb. 27, 2018 /PRN...
China Cord Blood Corporation to Report Third Quarter and First Nine Months Fiscal 2018 Financial Results
Earnings Call Scheduled for 8:00 a.m. ET on February 27, 2018 HONG KONG, Feb. 14, 2017 /PRNewswire/ -- China Cord Blood Corporation (NYSE: CO) (the "Company") today announced that it plans to release financial results for the third quarter and first nine months fiscal year 2018 onMonday, February...
China Cord Blood Corporation to Report Third Quarter and First Nine Months Fiscal 2018 Financial Results
Earnings Call Scheduled for 8:00 a.m. ET on February 27, 2018 HONG KONG, Feb. 14, 2017 /PRNewswire/ -- China Cord Blood Corporation (NYSE: CO) (the "Company") today announced that it plans to release financial results for the third quarter and first nine months fiscal year 2018 onMonday, February...
